woundvue and competition, page-8

@pistolstar there was also some discussion a month or so ago on the PhenoMATRIX system. I spoke to a friend of mine that is a medical scientist involved in this space, his comments (note: just his opinion, not advice) in relation to PhenoMATRIX was:

- they have a similar marketing message to APAS, but can not find any empirical evidence that the technology works at this stage
- they claim to be an image analysis solution, not an instrument
- customers have to buy the full WASPLab automation line to get access to what they claim. It is NOT a standalone instrument, so completely different to APAS
- they are NOT received FDA clearance and have been no clinical trials
- someone has to 'release' samples from the system so requires human intervention. APAS is completely automated
- cannot find any data to support whether PhenoMATRIX can perform enumeration

There no doubt will be a number of possible entrants to this space, but quite clearly LBT (through APAS) has a good head start on the competition, and first to market is pretty critical.